Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas

Modern Pathology

Volumn 12, Issue 12, 1999, Pages 1107-1111

  Nagura, Satoru ^a,d   Katoh, Ryohei ^a   Kawaoi, Akira ^a   Kobayashi, Makio ^b   Obara, Takao ^b   Omata, Kosaku ^c  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c YAMANASHI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Adrenal gland; Differential diagnosis; Growth activity; Immunohistochemistry; MIB 1; Paraganglioma; Pheochromocytoma

Indexed keywords

CYCLINE; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ADRENAL GLAND; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PREDICTION; PRIORITY JOURNAL; TUMOR GROWTH;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; ANTIGENS, NUCLEAR; AUTOANTIGENS; CHROMOGRANIN A; CHROMOGRANINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PHEOCHROMOCYTOMA; S100 PROTEINS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033398161     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Werbel SS, Ober KP. Pheochromocytoma: update on diagnosis, location, and management. Med Clin North Am 1995; 79:131-53.
2. Lack EE. Pheochromocytoma. In: Lack EE. Atlas of tumor pathology. Tumors of the adrenal gland and extra-adrenal paraganglia. 3rd Series. Washington DC: Armed Force Institute of Pathology; 1995. p. 223-60.
3. Leder L-D, Richter HJ. Pathology of renal and adrenal neoplasms. In: Leder L-D, Richter HJ. Renal and adrenal tumors. 2nd ed. Berlin: Springer-Verlag; 1987. p. 54-8.
4. Rubin E, Farber JL. The endocrine system. In: Rubin E, Farber JL. Pathology. 2nd ed. Philadelphia: Lippincott; 1994. p. 1140-2.
5. Warner NE, Strauss FH II. The adrenal gland. In: Silverberg SG, editor. Principles and practice of surgical pathology. Vol. 2. 2nd ed. New York: Churchill Livingstone; 1990. p. 1969-71.
6. Davis P, Peart WS, van't Hoff W. Malignant phaeochromocytoma with functioning metastases. Lancet 1955;2:274-5.
7. Kay S. Hyperplasia and neoplasia of the adrenal gland. Pathol Annu 1976;11:103-39.
8. Neville AM, Symington T. The pathology of the adrenal gland in Cushing's syndrome. J Pathol 1967;93:19-35.
9. Gallimore A. The adrenal medulla. In: McGee J O'D, Isaacson PG, Wright NA, editors. Oxford textbook of pathology. Vol. 2b. Oxford: Oxford University Press; 1992. p. 1988-9.
10. Linnoila RI, Keiser HR, Steinberg SM, Lack EE. Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathological study of 120 cases including unusual histologic features. Hum Pathol 1990;21:1168-80.
11. Meyers JS, Friedman E, McCrate M, Bauer WC. Prediction of early course of breast carcinoma by thymidine labeling. Cancer 1983;51:1879-86.
12. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 1982;218:474-5.
13. Ogata K, Kurki P, Celis JE, Nakamura RM, Tan EM. Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp Cell Res 1987;168:475-86.
14. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with proliferation. Int J Cancer 1983;31: 13-20.
15. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
16. Clarke MR, Weyant RJ, Watson CG, Carty SE. Prognostic markers in pheochromocytoma. Hum Pathol 1998;29:522-6.
17. Hartmann C-A, Gross U, Stein H. Cushing syndrome-associated pheochromocytoma and adrenal carcinoma: an immunohistological investigation. Path Res Pract 1992;188: 287-95.
18. Pang LC, Tsao KC. Flow cytometric DNA analysis for the determination of malignant potential in adrenal and extra-adrenal pheochromocytoma or paraganglioma. Arch Pathol Lab Med 1993;117:1142-7.
19. Heaney AP, O'Rourke D, Arthur K, Beatty OL, Russell CFJ, Sloan JM, et al. Flow cytometric analysis does not reliably differentiate benign from malignant phaeochromocytoma. Clin Endocrinol 1996;44:233-8.
20. Katoh R, Bray CE, Suzuki K, Komiyama A, Hemmi A, Kawaoi A. Growth activity in hyperplastic and neoplastic thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Hum Pathol 1995;26: 139-46.
21. Viberti L, Papotti M, Abbona GC, Celano A, Filosso PL, Bussolati G. Value of Ki-67 immunostaining in preoperative biopsies of carcinomas of the lung. Hum Pathol 1997;28: 189-92.
22. Popov Z, Hoznek A, Colombel M, Bastuji-Garin S, Lefrere-Belda MA, Bellot J, et al. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder. Cancer 1997;80:1472-81.
23. Abbona GC, Papotti M, Gaspard G, Bussolati G. Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol 1995;26:135-8.
24. Abe T, Sanno N, Osamura YR, Matsumoto K. Proliferative potential in pituitary adenomas: measurement by monoclonal antibody MIB-1. Acta Neurochir 1997;139:613-8.
25. Vargas MP, Vargas HI, Kleiner DE, Merino MJ. Adrenocortical neoplasms: role of prognostic markers MIB-1, p53, and RB. Am J Surg Pathol 1997;21:556-62.